Gabriele Zoppoli

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents

Gabriele Zoppoli, Marie Regairaz, Elisabetta Leo et al. · Proceedings of the National Academy of Sciences · 2012 · 375 citations

Medicine, Molecular Biology, Oncology +16

Fasting-mimicking diet and hormone therapy induce breast cancer regression

Irene Caffa, V. Spagnolo, Claudio Vernieri et al. · Nature · 2020 · 360 citations · Full text

Medicine, Endocrinology, Oncology +12

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

Martine Piccart, Laura van ‘t Veer, Coralie Poncet et al. · The Lancet Oncology · 2021 · 358 citations · Full text

Life Sciences, Biostatistics, Oncology +13

Genomic Characterization of Primary Invasive Lobular Breast Cancer

Christine Desmedt, Gabriele Zoppoli, Gunes Gundem et al. · Journal of Clinical Oncology · 2016 · 326 citations · Full text

Medicine, Molecular Genetics, Oncology +16